Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
More diversity would help doctors determine whether coronavirus treatments and vaccines will work for all population groups.
A fifth of the worldwide population with fatty liver disease consists of lean people.
Health advocate David Whiters has mastered some smooth moves since overcoming addiction and hep C.
During a clinical trial for a new hep C treatment, David Whiters got cured.
Clinical trials often exclude key patient populations, including children and people living with HIV or hepatitis B or C.
Encourage wider participation of children, people with HIV and those with brain metastasis.
As pharmaceutical companies race to develop treatments for NASH, they find one thing is missing: willing test subjects.
Clinical trial findings from the 2017 Liver Meeting
Hepatitis C clinical trials may be a good option for some people. Is it a good option for you?
Information about the pros and cons about participating in a hepatitis B clinical trial.
The PROP UP study is evaluating patient-reported outcomes associated with the treatment of hepatitis C infection and benefits of viral cure.
The FDA was reviewing BMS’ request for approval of new uses for Daklinza (daclatasvir) in combination with Gilead Sciences’ Sovaldi.
The FDA has granted priority review status to Gilead’s application for approval of a once-daily combo tablet of Sovaldi and velpatasvir.
There are many reasons why Hep C patients or other patients with conditions may want to consider participating in a clinical trial.
Many people who have lived with hep C for a long time are keen to get access to interferon-free treatment via a clinical trail.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.